Deutsche Bank Ag\ Gt Biopharma, Inc. Transaction History

Deutsche Bank Ag\

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$1.64 - $3.11 $17,751 - $33,662	-10,824 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$2.6 - $3.3 $2,958 - $3,755	-1,138 Reduced 9.51%	10,824 $31,000
Q4 2021 Feb 11, 2022	BUY	$3.05 - $7.08 $1,714 - $3,978	562 Added 4.93%	11,962 $37,000
Q3 2021 Nov 04, 2021	SELL	$6.68 - $15.26 $26,379 - $60,261	-3,949 Reduced 25.73%	11,400 $77,000
Q2 2021 Aug 11, 2021	BUY	$7.19 - $18.96 $110,359 - $291,017	15,349 New	15,349 $237,000

564

Ticker GTBP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 32,557,700
Market Cap $96.4M
Description
GT Biopharma, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of immuno-oncology products based on its proprietary Tri-specific Killer Engager (TriKE) fusion protein immune cell engager technology platform. It develops GTB-3550, a single-chain tri-specific recombinant fusion protein conjugate th...

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

Stay updated on Deutsche Bank Ag\ with notifications on news.